Condition: Patients Aged 50-75 and Requiring Colonoscopy · Sponsor: Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Colorectal cancer (CRC) is the second most common type of cancer worldwide. The European Union recommends national CRC screening for people aged between 50 and 74. Generally, an immunological test called FIT (Fecal Immunochemical Test), based on the quantitative detection of human haemoglobin, is performed on a stool sample. If the haemoglobin level is above the recommended threshold, a colonoscopy is recommended to detect colorectal lesions. Recent studies have identified potential microbiota signatures associated with colon cancer. In this study, we will analyze the microbiota of a population aged 50 to 75 years undergoing colonoscopy as part of routine care in order to confirm the presence of microbiota signatures associated with the presence of adenomas, advanced adenomas and CRC.
This description comes directly from the study's public registry record.
ROBERT BENAMOUZIG, Pr · 00148955434 · robert.benamouzig@aphp.fr
MOURAD BENALLAOUA, PhD · 0033148955024 · mourad.benallaoua@aphp.fr
Always discuss trial participation with your own doctor first.
| Hopital Avicenne, Centre de Recherche sur Volontaire | Bobigny, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06174233